Complete ONCO Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
ONCO Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 6 peer companies in Healthcare
P/E Ratio
$-0.43
-109.1%
Peer Median: 0.0x
EV/EBITDA
$0.00
-100.0%
Peer Median: 0.0x
P/S Ratio
$6.57
+39.7%
Peer Median: 1.8x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for ONCO's business model and current situation.
Multiple Comparison
| Multiple | ONCO Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -0.1x | 0.0x | 0.0x | -1201.3% | Undervalued |
| EV/EBITDA | Infinityx | 0.0x | 0.0x | Infinity% | Overvalued |
| P/S Ratio | 1.3x | 1.8x | 1.6x | -28.4% | Undervalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.00B | 0.0x | 0.0x | 0.0x | |
| $0.00B | 0.0x | 0.0x | 1.8x | |
| $0.01B | 0.0x | 0.0x | 0.0x | |
| $0.00B | 0.0x | 0.0x | 31.3x | |
| $0.00B | 0.0x | 0.0x | 1.3x | |
| $0.00B | 0.0x | 0.0x | 64.0x |